ArticlebioRxiv : the preprint server for biology2026
OPTIMIS: Optimizing Personalized Therapies through Integrated Multiscale Intelligent Simulation.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Controlling complex biological systems across multiple scales remains a major challenge in computational medicine, because whole-body disease behavior is closely shaped by noisy cellular events at much smaller scales. Standard deterministic models often miss this molecular variability, while fully stochastic simulations are too slow for the repeated, high-throughput interactions needed to train artificial intelligence. To address this problem, we developed a new AI-based framework that combines a discrete stochastic Gillespie algorithm for microscale receptor dynamics with continuous, nonlinear ordinary differential equations for systemic macroscale behavior. To reach the speed needed for deep reinforcement learning (RL), we compress this hybrid system into a differentiable Neural ODE surrogate that acts as a fast digital twin. As a proof of concept, we applied this framework to engineered cellular therapy and used RL agents to learn dynamic, closed-loop treatment policies inside the surrogate environment. By tracking microscopic, unpredictable cellular activity as an early-warning signal, the AI learned to continuously adjust the drug dose-anticipating and stopping dangerous immune reactions before they could spiral out of control. This computational advance improved successful control rates to more than 70% in highly unstable simulated phenotypes and provides a practical, general framework for adaptive intervention in multiscale biological systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.